BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22727903)

  • 1. TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide.
    Marcuzzi A; Secchiero P; Crovella S; Zauli G
    Cytokine; 2012 Oct; 60(1):43-6. PubMed ID: 22727903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muramyldipeptide augments the actions of lipopolysaccharide in mice by stimulating macrophages to produce pro-IL-1β and by down-regulation of the suppressor of cytokine signaling 1 (SOCS1).
    Shikama Y; Kuroishi T; Nagai Y; Iwakura Y; Shimauchi H; Takada H; Sugawara S; Endo Y
    Innate Immun; 2011 Feb; 17(1):3-15. PubMed ID: 19897531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide can modulate immune and endocrine responses during lipopolysaccharide-induced acute inflammation.
    Bik W; Wolinska-Witort E; Chmielowska M; Baranowska-Bik A; Rusiecka-Kuczalek E; Baranowska B
    Neuroimmunomodulation; 2004; 11(6):358-64. PubMed ID: 15467350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of metallothionein in coagulatory disturbance and systemic inflammation induced by lipopolysaccharide in mice.
    Inoue K; Takano H; Shimada A; Wada E; Yanagisawa R; Sakurai M; Satoh M; Yoshikawa T
    FASEB J; 2006 Mar; 20(3):533-5. PubMed ID: 16387980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production.
    Trepicchio WL; Bozza M; Pedneault G; Dorner AJ
    J Immunol; 1996 Oct; 157(8):3627-34. PubMed ID: 8871663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsis.
    Cziupka K; Busemann A; Partecke LI; Pötschke C; Rath M; Traeger T; Koerner P; von Bernstorff W; Kessler W; Diedrich S; Weiss FU; Maier S; Bröker BM; Heidecke CD
    Crit Care Med; 2010 Nov; 38(11):2169-74. PubMed ID: 20657274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
    Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
    Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
    J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
    Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P
    J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation.
    Bernardi S; Zauli G; Tikellis C; Candido R; Fabris B; Secchiero P; Cooper ME; Thomas MC
    Clin Sci (Lond); 2012 Nov; 123(9):547-55. PubMed ID: 22616837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL limits excessive host immune responses in bacterial meningitis.
    Hoffmann O; Priller J; Prozorovski T; Schulze-Topphoff U; Baeva N; Lunemann JD; Aktas O; Mahrhofer C; Stricker S; Zipp F; Weber JR
    J Clin Invest; 2007 Jul; 117(7):2004-13. PubMed ID: 17571163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex determination of murine seminal fluid cytokine profiles.
    Gopichandran N; Ekbote UV; Walker JJ; Brooke D; Orsi NM
    Reproduction; 2006 Mar; 131(3):613-21. PubMed ID: 16514204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A, cytokines, and corticosterone responses in germfree and conventional mice after lipopolysaccharide injection.
    Ikeda M; Hamada K; Sumitomo N; Okamoto H; Sakakibara B
    Biosci Biotechnol Biochem; 1999 Jun; 63(6):1006-10. PubMed ID: 10427685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin.
    Leiro J; Arranz JA; Yáñez M; Ubeira FM; Sanmartín ML; Orallo F
    Int Immunopharmacol; 2004 Jun; 4(6):763-78. PubMed ID: 15135318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].
    Bi MH; Wang BE; Zheng XX; Li M; Mayer K; Zhang SW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):461-4. PubMed ID: 18687171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines.
    An N; Song Y; Zhang X; Ci X; Li H; Cao Y; Zhang M; Cui J; Deng X
    Immunopharmacol Immunotoxicol; 2008; 30(3):437-46. PubMed ID: 18618311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice.
    Gong Q; Xu JF; Yin H; Liu SF; Duan LH; Bian ZL
    Scand J Immunol; 2009 Jan; 69(1):29-35. PubMed ID: 19140874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.
    Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A
    Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain.
    Xu DX; Wang H; Ning H; Zhao L; Chen YH
    J Pineal Res; 2007 Aug; 43(1):74-9. PubMed ID: 17614838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.